Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Varroa destructor octopamine receptor alpha-2 (VdOctα2R) is a G protein-coupled receptor (GPCR) that plays a vital role in the neurophysiology of the honey bee ectoparasitic mite, Varroa destructor (Blenau et al., 2013). As an alpha-adrenergic-like receptor, it is primarily activated by octopamine, which is the invertebrate functional analog of norepinephrine (Farooqui, 2012). This receptor is involved in modulating essential biological functions such as motor activity, sensory processing, and reproductive behaviors within the mite (Wu et al., 2021). Given its central role in the mite's nervous system and its divergence from vertebrate receptors, VdOctα2R is a significant target for acaricides designed to control Varroa infestations in apiculture (Ozoe, 2013). Chemical agents that interact with this receptor, including various formamidines and experimental biogenic amine analogs, can cause lethal overstimulation or neurological interference (Gross et al., 2017). However, the development of resistance to traditional acaricides and the need for honey bee safety necessitate the discovery of highly selective ligands that target VdOctα2R without affecting the host's own octopaminergic system (Blenau & Thamm, 2011).
Agonism or antagonism of the receptor disrupts biogenic amine signaling in the mite's central nervous system, leading to physiological dysfunction, paralysis, or death.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Varroa destructor octopamine receptor alpha-2 (VdOctα2R).